ABBVIE FDA Approval NDA 021402

NDA 021402

ABBVIE

FDA Drug Application

Application #021402

Documents

Letter2012-10-02
Label2002-07-24
Label2008-07-15
Label2014-01-15
Letter2002-07-24
Letter2008-07-15
Label2008-06-05
Review2002-11-25
Label2017-02-24
Label2017-02-24
Letter2017-03-02
Letter2017-03-02
Label2020-07-16
Letter2020-07-20
Letter2022-08-31
Label2022-08-31

Application Sponsors

NDA 021402ABBVIE

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004
Prescription005
Prescription006
Prescription007
Prescription008
Prescription009
Prescription010
Prescription011
Prescription012

Application Products

001TABLET;ORAL0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
002TABLET;ORAL0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
003TABLET;ORAL0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
004TABLET;ORAL0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
005TABLET;ORAL0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
006TABLET;ORAL0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
007TABLET;ORAL0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
008TABLET;ORAL0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
009TABLET;ORAL0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
010TABLET;ORAL0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
011TABLET;ORAL0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM
012TABLET;ORAL0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium1SYNTHROIDLEVOTHYROXINE SODIUM

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP2002-07-24STANDARD
LABELING; LabelingSUPPL11AP2008-04-20STANDARD
LABELING; LabelingSUPPL17AP2008-07-14STANDARD
LABELING; LabelingSUPPL20AP2011-01-14UNKNOWN
LABELING; LabelingSUPPL24AP2017-02-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2014-05-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL26AP2014-04-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL27AP2015-04-15STANDARD
LABELING; LabelingSUPPL28AP2017-02-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2015-11-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL30AP2016-05-13STANDARD
LABELING; LabelingSUPPL34AP2020-07-15STANDARD
LABELING; LabelingSUPPL36AP2022-08-30STANDARD

Submissions Property Types

ORIG1Null31
SUPPL20Null6
SUPPL24Null15
SUPPL25Null0
SUPPL26Null0
SUPPL27Null0
SUPPL28Null15
SUPPL29Null0
SUPPL30Null0
SUPPL34Null6
SUPPL36Null15

TE Codes

001PrescriptionAB1
002PrescriptionAB1
003PrescriptionAB1
004PrescriptionAB1
005PrescriptionAB1
006PrescriptionAB1
007PrescriptionAB1
008PrescriptionAB1
009PrescriptionAB1
010PrescriptionAB1
011PrescriptionAB1
012PrescriptionAB1

CDER Filings

ABBVIE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21402
            [companyName] => ABBVIE
            [docInserts] => ["",""]
            [products] => [{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"},{"drugName":"SYNTHROID","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"07\/15\/2020","submission":"SUPPL-34","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/021402s034lbl.pdf\"}]","notes":""},{"actionDate":"02\/23\/2017","submission":"SUPPL-28","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/021402s024s028lbl.pdf\"}]","notes":""},{"actionDate":"02\/23\/2017","submission":"SUPPL-24","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/021402s024s028lbl.pdf\"}]","notes":""},{"actionDate":"01\/14\/2011","submission":"SUPPL-20","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021402s020lbl.pdf\"}]","notes":""},{"actionDate":"07\/14\/2008","submission":"SUPPL-17","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/021402s017lbl.pdf\"}]","notes":""},{"actionDate":"04\/20\/2008","submission":"SUPPL-11","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/021402s011lbl.pdf\"}]","notes":""},{"actionDate":"07\/24\/2002","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2002\\\/21402lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"SYNTHROID","submission":"LEVOTHYROXINE SODIUM","actionType":"0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2020-07-15
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.